AI Chat Paper
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
{{expandStatus?'Exit ':''}}Advanced Search
Cancer treatment has witnessed the emergence of innovative stimuli-responsive nanotherapeutics aiming to overcome limitations associated with traditional drug delivery systems. Metal–organic frameworks (MOFs), a subset of inorganic nanomaterials, are known for their porous structures and versatile applications in integrated cancer diagnosis and therapy. Their noteworthy features include customizable porosity, diverse chemical configurations, adjustable sizes and shapes, and the potential for surface functionalization. The study delved into conventional cancer therapies, provided an overview of MOFs, and discussed various MOF synthesis approaches. Furthermore, this review explored the development of stimuli-responsive MOFs to enhance targeted drug delivery and bioimaging, improving the overall efficacy of cancer treatment, and investigated the applications of stimuli-responsive multifunctional MOFs in nanostructures activated by factors influencing precise drug delivery and bioimaging in cancers. pH, light, ions, temperature, magnetic field, redox reactions, and ATP contribute to the precise control of drug delivery and bioimaging processes. Designed multifunctional MOFs exhibit characteristic changes in response to external and internal stimuli, proving advantageous for drug release and bioimaging. Surface-modified MOFs with responsive features demonstrate excellent biocompatibility with noncancerous cells, efficient drug-loading capabilities, and nanocarrier-mediated targeted drug delivery to cancerous cells. Therefore, the innovative strategy of inorganic nanoscale MOFs with responsive properties holds significant promise for targeted therapeutic drug delivery and imaging across diverse malignancies. The growing interest in stimuli-activated MOFs will open new opportunities in cancer theragnostic applications.
A.L. Ho. Immunotherapy, chemotherapy, or both: Options for first-line therapy for patients with recurrent or metastatic head and neck squamous cell carcinoma. Journal of Clinical Oncology, 2023, 41(4): 736−741. https://doi.org/10.1200/jco.22.01408
M.M.F.A. Baig, C.F. Zhang, M.F. Akhtar, et al. Treatment of Wilms’ nephroblastoma cancer cells via EGFR targeting of dactinomycin loaded DNA-nanowires. Journal of Pharmaceutical Investigation, 2021, 51(2): 233−242. https://doi.org/10.1007/s40005-020-00509-5
R. Bajracharya, J.G. Song, B.R. Patil, et al. Functional ligands for improving anticancer drug therapy: Current status and applications to drug delivery systems. Drug Delivery, 2022, 29(1): 1959−1970. https://doi.org/10.1080/10717544.2022.2089296
M.T. Manzari, Y. Shamay, H. Kiguchi, et al. Targeted drug delivery strategies for precision medicines. Nature Reviews Materials, 2021, 6(4): 351−370. https://doi.org/10.1038/s41578-020-00269-6
H. Beck, M. Härter, B. Haß, et al. Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory. Drug Discovery Today, 2022, 27(6): 1560−1574. https://doi.org/10.1016/j.drudis.2022.02.015
M.Y. Errahmani, M. Locquet, D. Spoor, et al. Association between cardiac radiation exposure and the risk of arrhythmia in breast cancer patients treated with radiotherapy: A case–control study. Frontiers in Oncology, 2022, 12: 892882. https://doi.org/10.3389/fonc.2022.892882
D. Zhang, X.C. Xu, Y.A. Wei, et al. Prognostic role of DNA damage response genes mutations and their association with the sensitivity of olaparib in prostate cancer patients. Cancer Control, 2022, 29: 107327482211294. https://doi.org/10.1177/10732748221129451
T.L. Clarke, R. Mostoslavsky. DNA repair as a shared hallmark in cancer and ageing. Molecular Oncology, 2022, 16(18): 3352−3379. https://doi.org/10.1002/1878-0261.13285
N.F. Hosseini, R. Amini, M. Ramezani, et al. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer. Biomedicine &Pharmacotherapy, 2022, 155: 113690. https://doi.org/10.1016/j.biopha.2022.113690
A. Dadwal, A. Baldi, R. Kumar Narang. Nanoparticles as carriers for drug delivery in cancer. Artificial Cells,Nanomedicine,and Biotechnology, 2018, 46(sup2): 295−305. https://doi.org/10.1080/21691401.2018.1457039
S.H. Rim, G.P. Jr. Guy, K.R. Yabroff, et al. The impact of chronic conditions on the economic burden of cancer survivorship: A systematic review. Expert Review of Pharmacoeconomics &Outcomes Research, 2016, 16(5): 579−589. https://doi.org/10.1080/14737167.2016.1239533
Z. Li, S.R. Tan, S. Li, et al. Cancer drug delivery in the nano era: An overview and perspectives. Oncology Reports, 2017, 38(2): 611−624. https://doi.org/10.3892/or.2017.5718
W.T. Xia, Z.X. Tao, B. Zhu, et al. Targeted delivery of drugs and genes using polymer nanocarriers for cancer therapy. International Journal of Molecular Sciences, 2021, 22(17): 9118. https://doi.org/10.3390/ijms22179118
I.K. Herrmann, M.J.A. Wood, G. Fuhrmann. Extracellular vesicles as a next-generation drug delivery platform. Nature Nanotechnology, 2021, 16(7): 748−759. https://doi.org/10.1038/s41565-021-00931-2
Y.F. Jia, S.W. Chen, C.Y. Wang, et al. Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances. Frontiers in Bioengineering and Biotechnology, 2022, 10: 990145. https://doi.org/10.3389/fbioe.2022.990145
A.C. Anselmo, S. Mitragotri. Nanoparticles in the clinic: An update. Bioengineering &Translational Medicine, 2019, 4(3): e10143. https://doi.org/10.1002/btm2.10143
E. Kahraman, S. Güngör, Y. Özsoy. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery. Therapeutic Delivery, 2017, 8(11): 967−985. https://doi.org/10.4155/tde-2017-0075
F. Abedi-Gaballu, G. Dehghan, M. Ghaffari, et al. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy. Applied Materials Today, 2018, 12: 177−190. https://doi.org/10.1016/j.apmt.2018.05.002
A. Sharma, D. Shambhwani, S. Pandey, et al. Advances in lung cancer treatment using nanomedicines. ACS Omega, 2023, 8(1): 10−41. https://doi.org/10.1021/acsomega.2c04078
V. Singh, P. Kesharwani. Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics. Journal of Biomaterials Science,Polymer Edition, 2021, 32(14): 1882−1909. https://doi.org/10.1080/09205063.2021.1938859
G.J. Chen, Y.Y. Wang, R.S. Xie, et al. A review on core-shell structured unimolecular nanoparticles for biomedical applications. Advanced Drug Delivery Reviews, 2018, 130: 58−72. https://doi.org/10.1016/j.addr.2018.07.008
R. Rai, S. Alwani, I. Badea. Polymeric nanoparticles in gene therapy: New avenues of design and optimization for delivery applications. Polymers, 2019, 11(4): 745. https://doi.org/10.3390/polym11040745
B. Gorain, H. Choudhury, A.B. Nair, et al. Theranostic application of nanoemulsions in chemotherapy. Drug Discovery Today, 2020, 25(7): 1174−1188. https://doi.org/10.1016/j.drudis.2020.04.013
M.L. Du, Z.J. Yang, W.P. Lu, et al. Design and development of spirulina polysaccharide-loaded nanoemulsions with improved the antitumor effects of paclitaxel. Journal of Microencapsulation, 2020, 37(6): 403−412. https://doi.org/10.1080/02652048.2020.1767224
C. Dianzani, C. Monge, G. Miglio, et al. Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment. Cancers, 2020, 12(5): 1198. https://doi.org/10.3390/cancers12051198
E.B. Ribeiro, P.G.F. de Marchi, A.C. Honorio-França, et al. Interferon-gamma carrying nanoemulsion with immunomodulatory and anti-tumor activities. Journal of Biomedical Materials Research Part A, 2020, 108(2): 234−245. https://doi.org/10.1002/jbm.a.36808
S. Raj, S. Khurana, R. Choudhari, et al. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy. Seminars in Cancer Biology, 2021, 69: 166−177. https://doi.org/10.1016/j.semcancer.2019.11.002
B. Murugan, S. Sagadevan, I. Fatimah, et al. Smart stimuli-responsive nanocarriers for the cancer therapy – nanomedicine. Nanotechnology Reviews, 2021, 10(1): 933−953. https://doi.org/10.1515/ntrev-2021-0067
J.H. Yao, J.X. Feng, J. Chen. External-stimuli responsive systems for cancer theranostic. Asian Journal of Pharmaceutical Sciences, 2016, 11(5): 585−595. https://doi.org/10.1016/j.ajps.2016.06.001
Chansi, R. Bhardwaj, K. Hadwani, et al. Role of metal–organic framework (MOF) for pesticide sensing. In: Nanoscience for Sustainable Agriculture. Cham:Springer, 2019 75−99. https://doi.org/10.1007/978-3-319-97852-9_4
N. Mansouriieh, M.R. Sohrabi, M. Khosravi. Optimization of profenofos organophosphorus pesticide degradation by zero-valent bimetallic nanoparticles using response surface methodology. Arabian Journal of Chemistry, 2019, 12(8): 2524−2532. https://doi.org/10.1016/j.arabjc.2015.04.009
H. Furukawa, K.E. Cordova, M. O’Keeffe, et al. The chemistry and applications of metal–organic frameworks. Science, 2013, 341(6149): 1230444. https://doi.org/10.1126/science.1230444
W.K. Li, Y.P. Shi. Recent advances and applications of carbon nanotubes based composites in magnetic solid-phase extraction. TrAC Trends in Analytical Chemistry, 2019, 118: 652−665. https://doi.org/10.1016/j.trac.2019.06.039
J.B. DeCoste, G.W. Peterson. Metal–organic frameworks for air purification of toxic chemicals. Chemical Reviews, 2014, 114(11): 5695−5727. https://doi.org/10.1021/cr4006473
F. Maya, C. Palomino Cabello, R.M. Frizzarin, et al. Magnetic solid-phase extraction using metal–organic frameworks (MOFs) and their derived carbons. TrAC Trends in Analytical Chemistry, 2017, 90: 142−152. https://doi.org/10.1016/j.trac.2017.03.004
A. Ebrahimi, M. Mansournia. Zeolitic imidazolate framework-7: Novel ammonia atmosphere-assisted synthesis, thermal and chemical durability, phase reversibility and potential as highly efficient nanophotocatalyst. Chemical Physics, 2018, 511: 33−45. https://doi.org/10.1016/j.chemphys.2018.06.003
Y.J. Sun, L.W. Zheng, Y. Yang, et al. Metal–organic framework nanocarriers for drug delivery in biomedical applications. Nano-Micro Letters, 2020, 12(1): 103. https://doi.org/10.1016/j.ijepes.2020.106218
C.P. Raptopoulou. Metal–organic frameworks: Synthetic methods and potential applications. Materials, 2021, 14(2): 310. https://doi.org/10.3390/ma14020310
M. Kalaj, S.M. Cohen. Postsynthetic modification: An enabling technology for the advancement of metal–organic frameworks. ACS Central Science, 2020, 6(7): 1046−1057. https://doi.org/10.1021/acscentsci.0c00690
R. Anand, F. Borghi, F. Manoli, et al. Host–guest interactions in Fe(III)-trimesate MOF nanoparticles loaded with doxorubicin. The Journal of Physical Chemistry B, 2014, 118(29): 8532−8539. https://doi.org/10.1021/jp503809w
C. Carrillo-Carrión. Nanoscale metal–organic frameworks as key players in the context of drug delivery: Evolution toward theranostic platforms. Analytical and Bioanalytical Chemistry, 2020, 412(1): 37−54. https://doi.org/10.1007/s00216-019-02217-y
Y.L. Dai, C. Xu, X.L. Sun, et al. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment. Chemical Society Reviews, 2017, 46(12): 3830−3852. https://doi.org/10.1039/c6cs00592f
M.X. Wu, Y.W. Yang. Metal–Organic framework (MOF)-based drug/cargo delivery and cancer therapy. Advanced Materials, 2017, 29(23): 1606134. https://doi.org/10.1002/adma.201606134
Y. Yang, W.W. Zeng, P. Huang, et al. Smart materials for drug delivery and cancer therapy. VIEW, 2021, 2(2): 20200042. https://doi.org/10.1002/viw.20200042
M.R. Liu, H.L. Du, W.J. Zhang, et al. Internal stimuli-responsive nanocarriers for drug delivery: Design strategies and applications. Materials Science and Engineering:C, 2017, 71: 1267−1280. https://doi.org/10.1016/j.msec.2016.11.030
S. Mura, J. Nicolas, P. Couvreur. Stimuli-responsive nanocarriers for drug delivery. Nature Materials, 2013, 12(11): 991−1003. https://doi.org/10.1038/nmat3776
Y. Wang, J.H. Yan, N.C. Wen, et al. Metal–organic frameworks for stimuli-responsive drug delivery. Biomaterials, 2020, 230: 119619. https://doi.org/10.1016/j.biomaterials.2019.119619
M. Falsafi, A.S. Saljooghi, K. Abnous, et al. Smart metal organic frameworks: Focus on cancer treatment. Biomaterials Science, 2021, 9(5): 1503−1529. https://doi.org/10.1039/d0bm01839b
X.S. Guo, Y. Cheng, X.T. Zhao, et al. Advances in redox-responsive drug delivery systems of tumor microenvironment. Journal of Nanobiotechnology, 2018, 16(1): 74. https://doi.org/10.1186/s12951-018-0398-2
S.S.Das, P. Bharadwaj, M. Bilal, et al. Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis. Polymers, 2020, 12(6): 1397. https://doi.org/10.3390/polym12061397
F. Ke, Y.P. Yuan, L.G. Qiu, et al. Facile fabrication of magnetic metal–organic framework nanocomposites for potential targeted drug delivery. Journal of Materials Chemistry, 2011, 21(11): 3843. https://doi.org/10.1039/c0jm01770a
S. Sharma, K. Sethi, I. Roy. Magnetic nanoscale metal–organic frameworks for magnetically aided drug delivery and photodynamic therapy. New Journal of Chemistry, 2017, 41(20): 11860−11866. https://doi.org/10.1039/c7nj02032e
M. Oggianu, N. Monni, V. Mameli, et al. Designing magnetic NanoMOFs for biomedicine: Current trends and applications. Magnetochemistry, 2020, 6(3): 39. https://doi.org/10.3390/magnetochemistry6030039
B. Nirosha Yalamandala, W.T. Shen, S.H. Min, et al. Advances in functional metal–organic frameworks based on-demand drug delivery systems for tumor therapeutics. Advanced NanoBiomed Research, 2021, 1(8): 2100014. https://doi.org/10.1002/anbr.202100014
J.G. Liang, B.N. Yang, , X.D. Zhou, et al. Stimuli-responsive drug delivery systems for head and neck cancer therapy. Drug Delivery, 2021, 28(1): 272−284. https://doi.org/10.1080/10717544.2021.1876182
A.Y. Rwei, W.P. Wang, D.S. Kohane. Photoresponsive nanoparticles for drug delivery. Nano Today, 2015, 10(4): 451−467. https://doi.org/10.1016/j.nantod.2015.06.004
N. Fomina, J. Sankaranarayanan, A. Almutairi. Photochemical mechanisms of light-triggered release from nanocarriers. Advanced Drug Delivery Reviews, 2012, 64(11): 1005−1020. https://doi.org/10.1016/j.addr.2012.02.006
C.S. Linsley, B.M. Wu. Recent advances in light-responsive on-demand drug-delivery systems. Therapeutic Delivery, 2017, 8(2): 89−107. https://doi.org/10.4155/tde-2016-0060
C. Yan, Y. Jin, C.X. Zhao. Environment responsive metal–organic frameworks as drug delivery system for tumor therapy. Nanoscale Research Letters, 2021, 16(1): 140. https://doi.org/10.1186/s11671-021-03597-w
H. Lin, S.S. Gao, C. Dai, et al. A two-dimensional biodegradable niobium carbide (MXene) for photothermal tumor eradication in NIR-I and NIR-II biowindows. Journal of the American Chemical Society, 2017, 139(45): 16235−16247. https://doi.org/10.1021/jacs.7b07818
W.J. Sun, S.Y. Li, G.L. Tang, et al. Recent progress of nanoscale metal–organic frameworks in cancer theranostics and the challenges of their clinical application. International Journal of Nanomedicine, 2020, 14: 10195−10207. https://doi.org/10.2147/ijn.s230524
A. Karmakar, A.V. Desai, S.K. Ghosh. Ionic metal–organic frameworks (iMOFs): Design principles and applications. Coordination Chemistry Reviews, 2016, 307: 313−341. https://doi.org/10.1016/j.ccr.2015.08.007
M.R. Cai, G.S. Chen, L.Y. Qin, et al. Metal organic frameworks as drug targeting delivery vehicles in the treatment of cancer. Pharmaceutics, 2020, 12(3): 232. https://doi.org/10.3390/pharmaceutics12030232
Wu Y., Zhang J., He W., et al. Nanomaterials for targeting liver disease: research progress and future perspectives. Nano Biomedicine and Engineering, 2023, 15(2): 199−224. https://doi.org/10.26599/NBE.2023.9290024
Z. Cheng, M.Y. Li, R. Dey, et al. Nanomaterials for cancer therapy: Current progress and perspectives. Journal of Hematology &Oncology, 2021, 14(1): 85. https://doi.org/10.1186/s13045-021-01096-0
Zhou W., Zhang J., Wang X., et al. Radiolabeled tracing techniques illuminating blood pharmacokinetics in nanomedicine. Nano Biomedicine and Engineering, 2024, 16(1): 48−63. https://doi.org/10.26599/NBE.2024.9290048
Y.Q. Zhang, J. Fang, S.Y. Ye, et al. A hydrogen sulphide-responsive and depleting nanoplatform for cancer photodynamic therapy. Nature Communications, 2022, 13: 1685. https://doi.org/10.1038/s41467-022-29284-7
Q.Q. Sun, H.T. Bi, Z. Wang, et al. Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal–organic frameworks for efficient antitumor therapy. Biomaterials, 2019, 223: 119473. https://doi.org/10.1016/j.biomaterials.2019.119473
R. Abazari, F. Ataei, A. Morsali, et al. A luminescent amine-functionalized metal–organic framework conjugated with folic acid as a targeted biocompatible pH-responsive nanocarrier for apoptosis induction in breast cancer cells. ACS Applied Materials &Interfaces, 2019, 11(49): 45442−45454. https://doi.org/10.1021/acsami.9b16473
W.C. Liu, Y.Y. Zhong, X.X. Wang, et al. A porous Cu(II)-based metal–organic framework carrier for pH-controlled anticancer drug delivery. Inorganic Chemistry Communications, 2020, 111: 107675. https://doi.org/10.1016/j.inoche.2019.107675
B.H. Song, X. Ding, Z.F. Zhang, et al. Efficient drug delivery of 5-fluorouracil by a biocompatible Zn-metal–organic framework nanostructure and anti-liver cancer activity study. Journal of the Iranian Chemical Society, 2019, 16(2): 333−340. https://doi.org/10.1007/s13738-018-1520-y
F.-M. Zhang, H. Dong, X. Zhang, et al. Postsynthetic modification of ZIF-90 for potential targeted codelivery of two anticancer drugs. ACS Applied Materials &Interfaces, 2017, 9(32): 27332−27337. https://doi.org/10.1021/acsami.7b08451
A. Cabrera-García, E. Checa-Chavarria, E. Rivero-Buceta, et al. Amino modified metal–organic frameworks as pH-responsive nanoplatforms for safe delivery of camptothecin. Journal of Colloid and Interface Science, 2019, 541: 163−174. https://doi.org/10.1016/j.jcis.2019.01.042
X.M. Jia, Z.Y. Yang, Y.J. Wang, et al. Hollow mesoporous silica@metal–organic framework and applications for pH-responsive drug delivery. ChemMedChem, 2018, 13(5): 400−405. https://doi.org/10.1002/cmdc.201800019
H. Ren, L.Y. Zhang, J.P. An, et al. Polyacrylic acid@zeolitic imidazolate framework-8 nanoparticles with ultrahigh drug loading capability for pH-sensitive drug release. Chem Commun, 2014, 50(8): 1000−1002. https://doi.org/10.1039/c3cc47666a
T. Kundu, S. Mitra, P. Patra, et al. Mechanical downsizing of a gadolinium(III)-based metal–organic framework for anticancer drug delivery. Chemistry – A European Journal, 2014, 20(33): 10514−10518. https://doi.org/10.1002/chem.201402244
F. Duan, X.C. Feng, X.J. Yang, et al. A simple and powerful co-delivery system based on pH-responsive metal–organic frameworks for enhanced cancer immunotherapy. Biomaterials, 2017, 122: 23−33. https://doi.org/10.1016/j.biomaterials.2017.01.017
A.Q. Ma, R. Zhang. Facile synthesis of redox-responsive paclitaxel drug release platform using metal–organic frameworks (ZIF-8) for gastric cancer treatment. Materials Research Express, 2020, 7(9): 095402. https://doi.org/10.1088/2053-1591/abb2ce
C. Liu, X.Y. Xu, J.N. Zhou, et al. Redox-responsive tumor targeted dual-drug loaded biocompatible metal–organic frameworks for enhancing anticancer cytotoxicity. BMC Materials, 2020, 2: 7. https://doi.org/10.1186/s42833-020-00013-y
B.Q. Lei, M.F. Wang, Z.L. Jiang, et al. Constructing redox-responsive metal–organic framework nanocarriers for anticancer drug delivery. ACS Applied Materials &Interfaces, 2018, 10(19): 16698−16706. https://doi.org/10.1021/acsami.7b19693
K.D. Lu, C.B. He, W.B. Lin. Nanoscale metal–organic framework for highly effective photodynamic therapy of resistant head and neck cancer. Journal of the American Chemical Society, 2014, 136(48): 16712−16715. https://doi.org/10.1021/ja508679h
J.J. Chen, Y.F. Zhu, S. Kaskel. Porphyrin-based metal–organic frameworks for biomedical applications. Angewandte Chemie International Edition, 2021, 60(10): 5010−5035. https://doi.org/10.1002/anie.201909880
Y.C. Zhang, Q.L. Wang, G. Chen, et al. DNA-functionalized metal–organic framework: Cell imaging, targeting drug delivery and photodynamic therapy. Inorganic Chemistry, 2019, 58(10): 6593−6596. https://doi.org/10.1021/acs.inorgchem.9b00734
D.M. Liu, C.B. He, C. Poon, et al. Theranostic nanoscale coordination polymers for magnetic resonance imaging and bisphosphonate delivery. Journal of Materials Chemistry B, 2014, 2(46): 8249−8255. https://doi.org/10.1039/c4tb00751d
S. Li, K. Bi, L. Xiao, et al. Facile preparation of magnetic metal organic frameworks core–shell nanoparticles for stimuli-responsive drug carrier. Nanotechnology, 2017, 28(49): 495601. https://doi.org/10.1088/1361-6528/aa91c4
A.K. Ebrahimi, M. Barani, I. Sheikhshoaie. Fabrication of a new superparamagnetic metal–organic framework with core-shell nanocomposite structures: Characterization, biocompatibility, and drug release study. Materials Science &Engineering C,Materials for Biological Applications, 2018, 92: 349−355. https://doi.org/10.1016/j.msec.2018.07.010
W.H. Chen, X. Yu, A. Cecconello, et al. Stimuli-responsive nucleic acid-functionalized metal–organic framework nanoparticles using pH- and metal-ion-dependent DNAzymes as locks. Chemical Science, 2017, 8(8): 5769−5780. https://doi.org/10.1039/c7sc01765k
W.X. Lin, Q. Hu, J.C. Yu, et al. Low cytotoxic metal–organic frameworks as temperature-responsive drug carriers. ChemPlusChem, 2016, 81(8): 668. https://doi.org/10.1002/cplu.201600327
J.Y.R. Silva, Y.G. Proenza, L.L. da Luz, et al. A thermo-responsive adsorbent-heater-thermometer nanomaterial for controlled drug release: (ZIF-8, EuxTby)@AuNP core-shell. Materials Science &Engineering C,Materials for Biological Applications, 2019, 102: 578−588.
X T Yang , Q Tang, Y Jiang, et al. Nanoscale ATP-Responsive Zeolitic Imidazole Framework-90 as a General Platform for Cytosolic Protein Delivery and Genome Editing. J. Am. Chem. Soc., 2019, 141(9): 3782−3786. https://doi.org/10.1021/jacs.8b11996
W. Pan, B.J. Cui, K.Y. Wang, et al. ATP-triggered mitochondrial cascade reactions for cancer therapy with nanoscale zeolitic imidazole framework-90. Theranostics, 2021, 11(16): 7869−7878. https://doi.org/10.7150/thno.59593
X.X. Chen, M.J. Hou, G.J. Mao, et al. ATP-responsive near-infrared fluorescence MOF nanoprobe for the controlled release of anticancer drug. Microchimica Acta, 2021, 188(9): 287. https://doi.org/10.1007/s00604-021-04953-4
L. Zhang, S.S. Wan, C.X. Li, et al. An adenosine triphosphate-responsive autocatalytic Fenton nanoparticle for tumor ablation with self-supplied H2O2 and acceleration of Fe(III)/Fe(II) conversion. Nano Letters, 2018, 18(12): 7609−7618. https://doi.org/10.1021/acs.nanolett.8b03178
S.S. Wan, M.D. Liu, Q. Cheng, et al. A mitochondria-driven metabolic sensing nanosystem for oxygen availability and energy blockade of cancer. Advanced Therapeutics, 2020, 3(6): 2000019. https://doi.org/10.1002/adtp.202000019
Y.T. Li, J.L. Zhou, L. Wang, et al. Endogenous hydrogen sulfide-triggered MOF-based nanoenzyme for synergic cancer therapy. ACS Applied Materials &Interfaces, 2020, 12(27): 30213−30220. https://doi.org/10.1021/acsami.0c08659
Y. Ma, X.Y. Li, A.J. Li, et al. H2S-activable MOF nanoparticle photosensitizer for effective photodynamic therapy against cancer with controllable singlet-oxygen release. Angewandte Chemie International Edition, 2017, 56(44): 13752−13756. https://doi.org/10.1002/anie.201708005
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY) (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
京公网安备11010802044758号